Cargando…
AF1q: A Novel Mediator of Basal and 4-HPR-Induced Apoptosis in Ovarian Cancer Cells
BACKGROUND: Fenretinide (4-HPR) is a synthetic retinoid that exhibits potent antitumor and chemopreventive activities against different malignancies, including ovarian tumors. We previously showed that in ovarian cancer cells, 4-HPR induces apoptosis through a signaling cascade starting from reactiv...
Autores principales: | Tiberio, Paola, Cavadini, Elena, Callari, Maurizio, Daidone, Maria Grazia, Appierto, Valentina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383705/ https://www.ncbi.nlm.nih.gov/pubmed/22761939 http://dx.doi.org/10.1371/journal.pone.0039968 |
Ejemplares similares
-
Involvement of AF1q/MLLT11 in the progression of ovarian cancer
por: Tiberio, Paola, et al.
Publicado: (2017) -
Sodium 4-Carboxymethoxyimino-(4-HPR) a Novel Water-Soluble Derivative of 4-Oxo-4-HPR Endowed with In Vivo Anticancer Activity on Solid Tumors
por: Tiberio, Paola, et al.
Publicado: (2017) -
Challenges in Using Circulating miRNAs as Cancer Biomarkers
por: Tiberio, Paola, et al.
Publicado: (2015) -
Proposal of supervised data analysis strategy of plasma miRNAs from hybridisation array data with an application to assess hemolysis-related deregulation
por: Landoni, Elena, et al.
Publicado: (2015) -
4-oxo-N-(4-hydroxyphenyl)retinamide: Two Independent Ways to Kill Cancer Cells
por: Tiberio, Paola, et al.
Publicado: (2010)